If Tirzepatide worked — but suddenly stopped — you’re not alone, and it’s not the failure most patients think it is. Across the country, patients are reporting the same experience: early success followed by a frustrating plateau that traditional advice doesn’t explain. What’s emerging instead is a new phase in metabolic care, where plateau is no longer the end of treatment — it’s the signal to evolve it. California Trim Clinic is among the providers interpreting this shift in real time. As demand rises for answers beyond “eat less, move more,” the clinic is guiding patients through structured next steps — including advanced therapies like retatrutide, which are rapidly becoming the focus of post-GLP-1 care.
